A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents
From MaRDI portal
Publication:3064270
DOI10.1111/j.1541-0420.2009.01363.xzbMath1203.62181WikidataQ41241253 ScholiaQ41241253MaRDI QIDQ3064270
Publication date: 21 December 2010
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc2889231
62P10: Applications of statistics to biology and medical sciences; meta analysis
62F15: Bayesian inference
92C50: Medical applications (general)
Related Items
Cites Work
- Unnamed Item
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Continual Reassessment Method for Ordered Groups
- Dose-Finding with Two Agents in Phase I Oncology Trials
- Design and Analysis of Phase I Clinical Trials
- Designs for Single- or Multiple-Agent Phase I Trials
- Continual Reassessment Method: A Likelihood Approach
- Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials
- Two‐Dimensional Dose Finding in Discrete Dose Space